Cargando…
Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry
To compare complications and mortality between patients that required extracorporeal membrane oxygenation (ECMO) support for acute respiratory distress syndrome (ARDS) due to COVID-19 and non-COVID-19 viral pathogens. DESIGN: Retrospective observational cohort study. SETTING: Adult patients in the E...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901999/ https://www.ncbi.nlm.nih.gov/pubmed/36760815 http://dx.doi.org/10.1097/CCE.0000000000000861 |
_version_ | 1784883151260090368 |
---|---|
author | Chandel, Abhimanyu Puri, Nitin Damuth, Emily Potestio, Christopher Peterson, Lars-Kristofer N. Ledane, Julia Rackley, Craig R. King, Christopher S. Conrad, Steven A. Green, Adam |
author_facet | Chandel, Abhimanyu Puri, Nitin Damuth, Emily Potestio, Christopher Peterson, Lars-Kristofer N. Ledane, Julia Rackley, Craig R. King, Christopher S. Conrad, Steven A. Green, Adam |
author_sort | Chandel, Abhimanyu |
collection | PubMed |
description | To compare complications and mortality between patients that required extracorporeal membrane oxygenation (ECMO) support for acute respiratory distress syndrome (ARDS) due to COVID-19 and non-COVID-19 viral pathogens. DESIGN: Retrospective observational cohort study. SETTING: Adult patients in the Extracorporeal Life Support Organization registry. PATIENTS: Nine-thousand two-hundred ninety-one patients that required ECMO for viral mediated ARDS between January 2017 and December 2021. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The primary outcomes of interest were mortality during ECMO support and prior to hospital discharge. Time-to-event analysis and logistic regression were used to compare outcomes between the groups. Among 9,291 included patients, 1,155 required ECMO for non-COVID-19 viral ARDS and 8,136 required ECMO for ARDS due to COVID-19. Patients with COVID-19 had longer duration of ECMO (19.6 d [interquartile range (IQR), 10.1–34.0 d] vs 10.7 d [IQR, 6.3–19.7 d]; p < 0.001), higher mortality during ECMO support (44.4% vs 27.5%; p < 0.001), and higher in-hospital mortality (50.2% vs 34.5%; p < 0.001). Further, patients with COVID-19 were more likely to experience mechanical and clinical complications (membrane lung failure, pneumothorax, intracranial hemorrhage, and superimposed infection). After adjusting for pre-ECMO disease severity, patients with COVID-19 were more than two times as likely to die in the hospital compared with patients with non-COVID-19 viral ARDS. CONCLUSIONS: Patients with COVID-19 that require ECMO have longer duration of ECMO, more complications, and higher in-hospital mortality compared with patients with non-COVID-19–related viral ARDS. Further study in patients with COVID-19 is critical to identify the patient phenotype most likely to benefit from ECMO and to better define the role of ECMO in the management of this disease process. |
format | Online Article Text |
id | pubmed-9901999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-99019992023-02-08 Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry Chandel, Abhimanyu Puri, Nitin Damuth, Emily Potestio, Christopher Peterson, Lars-Kristofer N. Ledane, Julia Rackley, Craig R. King, Christopher S. Conrad, Steven A. Green, Adam Crit Care Explor Original Clinical Report To compare complications and mortality between patients that required extracorporeal membrane oxygenation (ECMO) support for acute respiratory distress syndrome (ARDS) due to COVID-19 and non-COVID-19 viral pathogens. DESIGN: Retrospective observational cohort study. SETTING: Adult patients in the Extracorporeal Life Support Organization registry. PATIENTS: Nine-thousand two-hundred ninety-one patients that required ECMO for viral mediated ARDS between January 2017 and December 2021. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The primary outcomes of interest were mortality during ECMO support and prior to hospital discharge. Time-to-event analysis and logistic regression were used to compare outcomes between the groups. Among 9,291 included patients, 1,155 required ECMO for non-COVID-19 viral ARDS and 8,136 required ECMO for ARDS due to COVID-19. Patients with COVID-19 had longer duration of ECMO (19.6 d [interquartile range (IQR), 10.1–34.0 d] vs 10.7 d [IQR, 6.3–19.7 d]; p < 0.001), higher mortality during ECMO support (44.4% vs 27.5%; p < 0.001), and higher in-hospital mortality (50.2% vs 34.5%; p < 0.001). Further, patients with COVID-19 were more likely to experience mechanical and clinical complications (membrane lung failure, pneumothorax, intracranial hemorrhage, and superimposed infection). After adjusting for pre-ECMO disease severity, patients with COVID-19 were more than two times as likely to die in the hospital compared with patients with non-COVID-19 viral ARDS. CONCLUSIONS: Patients with COVID-19 that require ECMO have longer duration of ECMO, more complications, and higher in-hospital mortality compared with patients with non-COVID-19–related viral ARDS. Further study in patients with COVID-19 is critical to identify the patient phenotype most likely to benefit from ECMO and to better define the role of ECMO in the management of this disease process. Lippincott Williams & Wilkins 2023-02-03 /pmc/articles/PMC9901999/ /pubmed/36760815 http://dx.doi.org/10.1097/CCE.0000000000000861 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Clinical Report Chandel, Abhimanyu Puri, Nitin Damuth, Emily Potestio, Christopher Peterson, Lars-Kristofer N. Ledane, Julia Rackley, Craig R. King, Christopher S. Conrad, Steven A. Green, Adam Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry |
title | Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry |
title_full | Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry |
title_fullStr | Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry |
title_full_unstemmed | Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry |
title_short | Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry |
title_sort | extracorporeal membrane oxygenation for covid-19: comparison of outcomes to non-covid-19–related viral acute respiratory distress syndrome from the extracorporeal life support organization registry |
topic | Original Clinical Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901999/ https://www.ncbi.nlm.nih.gov/pubmed/36760815 http://dx.doi.org/10.1097/CCE.0000000000000861 |
work_keys_str_mv | AT chandelabhimanyu extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT purinitin extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT damuthemily extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT potestiochristopher extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT petersonlarskristofern extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT ledanejulia extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT rackleycraigr extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT kingchristophers extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT conradstevena extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry AT greenadam extracorporealmembraneoxygenationforcovid19comparisonofoutcomestononcovid19relatedviralacuterespiratorydistresssyndromefromtheextracorporeallifesupportorganizationregistry |